Johnson & Johnson wins EU approval for Tremfya in pediatric plaque psoriasis, making it the first IL-23 inhibitor cleared for any pediatric condition.

UPST expands partnerships with Tech CU, Peak and CAFCU, growing its AI lending network past 100 partners and widening personal, auto and HELOC offerings.

AMZN stock is gaining momentum as AI investments boost AWS growth and enhance retail performance, driving revenue gains across both core businesses.

Find out why Zacks has given Natural Grocers an "Outperform" rating, being the first on Wall Street to initiate coverage on the stock. Explore how organic retail leadership, margin-boosting strategies, and wellness-driven demand fuel its growth potential.

Shopify's Merchant Solutions revenues surge 38.2% as GMV hits $92B, driven by B2B, Shop Pay and offline commerce strength.

The TJX Companies leans on its treasure-hunt model this holiday season, with frequent new arrivals, strong branded supply, and everyday value pricing.

A patient who was being treated with Pfizer's hemophilia drug, Hympavzi, as part of a long-term study died after experiencing serious side effects, the company said.

DUOL's AI-driven scalability, rapid course expansion and discounted valuation give it an edge over APP despite strong growth at both companies.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Sprouts To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Sprouts between June 4, 2025 and October 29, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Dec. 23, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Sprouts Farmers Market, Inc. ("Sprouts" or …

LOS ANGELES, Dec. 23, 2025 (GLOBE NEWSWIRE) -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Integer Holdings Corporation (“Integer” or “the Company”) (NYSE: ITGR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 25, 2024 and October 22, 2025, inclusive (the “Class Period”), are encouraged to contact the firm before February 9, 2026.

POET Technologies is upgraded from Hold to Buy due to the Marvell-Celestial AI deal, highlighting POET's strategic importance in AI data center infrastructure. POET's technology is a key enabler of Celestial AI's Photonic Fabric platform, positioning it as a strategic supply chain partner. Marvell's acquisition of Celestial AI indirectly validates POET's technology and increases the likelihood of POET being targeted for acquisition by a major IT player.

SAN DIEGO, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Stride, Inc. (NYSE: LRN) securities between October 22, 2024 and October 28, 2025, both dates inclusive (the “Class Period”), have until Monday, January 12, 2026 to seek appointment as lead plaintiff of the Stride class action lawsuit. Captioned MacMahon v.

Bristol-Myers Squibb remains a "Buy," driven by robust Q3 results and a positive technical setup heading into 2026. BMY raised FY 2025 guidance, with operating EPS targeted at $6.40–$6.60 and net sales above consensus, reflecting pipeline strength. Shares trade at a discount to peers with a 14% FCF yield, while multiple late-stage drugs and recent acquisitions support long-term growth.

W. R. Berkley Corporation maintains solid investment-grade credit ratings and a strong balance sheet with $43.7B in assets and $3.08B in debt. WRB's baby bonds, all investment-grade, currently trade below par with yields to worst around 7%, offering attractive risk-adjusted returns. WRB has delivered robust long-term total returns: 20.8% over 5 years and 17% over 10 years, outperforming insurance sector benchmarks.

Arthur J. Gallagher stock gains on the back of strategic acquisitions, solid retention and improving renewal premiums, as well as financial flexibility.

WMT's ad revenues surge 53% in Q3, with retail media and data-driven ads lifting margins and reshaping its profit mix.

NVO and AMGN square off as GLP-1 leadership, pipeline depth, and diversification set up a compelling healthcare stock comparison.

Q3 GDP posted its strongest growth number in two years, and half a point higher than Q2's +3.8%.

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, Dec. 23:

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Firefly Aerospace To Contact Him Directly To Discuss Their Options If you purchased or otherwise acquired: (a) Firefly common stock pursuant and/or traceable to the Offering Documents (defined below) issued in connection with the Company's initial public offering conducted on or about August 7, 2025 (the "IPO" or "Offering"); and/or (b) Firefly securities between August 7, 2025 and September 29, 2025, both dates inclusive (the "Class Period") and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at …